The Covid-19 vaccine of Biological-E is currently undergoing phase-3 clinical trial after showing promising results in phase 1 and 2 trials
These exemptions have been made in light of the huge vaccination requirements in India in the wake of the recent surge of Covid-19 cases.
The B.1.617 variant was first detected in India and was divided into three lineages - B.1.617.1, B.1.617.2, and B.1.617.3.
The number of people who have recuperated from the disease surged to 2,61,79,085.
The Covid-19 death toll has climbed to 3,31,895 with 2,795 fresh fatalities, the lowest reported in 35 days
The number of active cases has reduced to 21,14,508, comprising 7.58 % of the total infections.
A total of 1,86,364 new coronavirus infections were reported in a day while the death toll climbed to 3,18,895 with 3,660 daily deaths.
The death toll due to the disease rose to 3,15,235 with 3,847 fresh fatalities being reported in a span of 24 hours.
Over 34 % of the population above 45 years has received at least the first dose of the Covid-19 vaccine in India to date
India's daily recoveries continue to outnumber the daily new cases for the 12th consecutive day